Crescendo Platform

Overview

Multimodal patient safety platform integrating genomic, transcriptomic, and epigenomic data for personalized drug screening at BioHack 2024.

Problem

Precision medicine requires integrating multiple data types for patient-specific treatment recommendations. Quality control and reproducibility remain key challenges.

Solution

Built ML pipelines for multimodal data integration with quality control protocols ensuring reproducibility in drug efficacy testing. Designed scalable architecture for patient-specific treatment recommendations.

Impact

• Multimodal integration: Genomic, transcriptomic, and epigenomic data
• Quality-controlled: Reproducible drug efficacy testing
• Scalable architecture: Patient-specific recommendations
• Precision medicine: Advancing personalized treatment approaches